Neuronetics
STIM
105 hedge funds and large institutions have $351M invested in Neuronetics in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 11 closing their positions.
26,200% more call options, than puts
Call options by funds: $1.05M | Put options by funds: $4K
200% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 11
46% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 24
37% more capital invested
Capital invested by funds: $256M → $351M (+$94.3M)
27% more funds holding
Funds holding: 83 → 105 (+22)
8.96% more ownership
Funds ownership: 81.61% → 90.57% (+9%)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
+$17.2M |
| 2 |
BlackRock
New York
|
+$15.2M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$11.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.25M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$4.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$11.4M |
| 2 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$8.72M |
| 3 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$6.26M |
| 4 |
IVM
InterWest Venture Management
San Francisco,
California
|
-$6.15M |
| 5 |
Renaissance Technologies
New York
|
-$4.33M |
STIM Hedge Fund Activity: Q2 2021 in Review
105 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q2 2021, worth a combined $351M — up 37% from $256M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new STIM positions and 11 closed out — a net gain of 22 holders — while 35 added to existing stakes and 24 trimmed.
The largest buyer was Cannell Capital, adding an estimated $17.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $11.4M sold.
- 105 institutional investors held Neuronetics (STIM) as of Q2 2021, up from 83 in Q1 2021.
- Funds reported $351M of Neuronetics stock for Q2 2021, up 37% quarter-over-quarter.
- 33 funds opened new Neuronetics positions in Q2 2021 and 11 closed out, a net change of +22 holders.
- The largest Neuronetics buyer in Q2 2021 was Cannell Capital, an estimated $17.2M added.
- The largest Neuronetics seller in Q2 2021 was Deerfield Management, an estimated $11.4M sold.
Based on aggregated 13F filings for Q2 2021.